Skip to content

ISZO CAPITAL MANAGEMENT LP

Follow

13F filer, CIK 1607925, NEW YORK, NY

ISZO CAPITAL MANAGEMENT LP reported $7,479,907 across 7 holdings for the quarter ended 2022-12-31, in a 13F-HR filed 2023-02-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001013594-23-000255

Period
2022-12-31
Reported value
$7.48M
Holdings
7
Top 10 weight
100%
New
2
Sold out
1

Part of the filer group ISZO CAPITAL LP

How groups are built

Stakes and trades reported after 2022-12-31

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • LQDA LIQUIDIA CORPORATION: 13G 4,712,900 shares, 5.2% of the class, 13G filed 2026-11-19, 0001013594-26-001217Timeline
    Accepted , ingested

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CVNAnew+150,000$711K
AMPYnew+953$8.38K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
NTPIFexited-6,918,372-$29.2M
LFCRreduced-1,156,874-$7.5M
LNTHreduced-119,173-$6.07M
CBLreduced-54,000-$1.25M
CCELreduced-83,842-$355K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2022

Share positions as resolved from 13F-HR 0001013594-23-000255, largest first. % of portfolio is the value over $7,479,906, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
LFCRLIFECORE BIOMEDICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: 2,176,949 shares; 2022Q2: 2,241,394 shares; 2022Q3: 1,530,652 shares; 2022Q4: 373,778 shares 373,778$2.42M32.38%-1,156,874Timeline
CBLCBL & ASSOC PPTYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: 131,100 shares; 2022Q2: 81,810 shares; 2022Q3: 132,316 shares; 2022Q4: 78,316 shares 78,316$1.81M24.17%-54,000Timeline
LNTHLANTHEUS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: 136,250 shares; 2022Q4: 17,077 shares 17,077$870K11.63%-119,173Timeline
CORBFGLOBAL CORD BLOOD CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: 279,495 shares; 2022Q4: 279,495 shares 279,495$836K11.17%0Timeline
CCELCRYO-CELL INTL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: 357,107 shares; 2022Q2: 353,210 shares; 2022Q3: 278,873 shares; 2022Q4: 195,031 shares 195,031$825K11.03%-83,842Timeline
CVNACARVANA COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 150,000 shares 150,000$711K9.51%newTimeline
AMPYAMPLIFY ENERGY CORP NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: not reported; 2022Q4: 953 shares 953$8.38K0.11%newTimeline

Sold out in Q4 2022

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
NTPIFNAM TAI PROPERTY INC6,918,372$29.2Mshares

How Q4 2022 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001013594-23-000255 base2023-02-14acceptance time not in the bulk data set